Healwell AI Inc.
TSX:AIDX.TO · Toronto Stock Exchange
-$0.01 today
Vol 0.42M · Avg 0.38M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-37.9%
avg -210.3%
ROIC
-12.1%
avg -23.3%
ROA
-16.5%
avg -24.8%
Analysis
ROIC is currently the strongest return metric at -12.1% versus its period average of -23.3%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Madeline D. Walker | President of MCI Medical | $627,871.00 | — | 79 | — | — |
James Lee | Chief Executive Officer | $394,983.00 | — | — | — | — |
Alexander Julian Dobranowski | Founder, President, MD & Director | $350,000.00 | — | — | — | — |
Anthony Lam | Chief Financial Officer | $300,000.00 | — | — | — | — |
Brad Porter | Chief Commercial Officer & Director | $296,237.00 | — | — | — | — |
Aaron Leibtag | Pentavere Research Group -CEO | $250,000.00 | — | — | — | — |
Blake Corbet | Senior Vice President of Corporate Development | $225,000.00 | — | — | — | — |
Noah Crampton | Chief Executive Officer of Mutuo Health Solutions | — | — | — | — | — |
Mark Findlay | Senior Vice President of Sales & Marketing for Canada | — | — | — | — | — |
Sacha Gera | Chief Operating Officer | — | — | — | — | — |
Nolan Reeds | Vice President of Marketing & Communications | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | -42.5% | +63.2% (7yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Recent growth has been strongest in Revenue at -42.5% over three years. Forward estimates point to Revenue at +63.2% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Who manages AIDX.TO?
Healwell AI Inc. (AIDX.TO) lists 11 active executives. The top listed executive is Aaron Leibtag, Pentavere Research Group -CEO.
Explore More
Continue the stock analysis
Jump to another research area for this company.